We use cookies for a better user experience. Read our Privacy Policy

I Agree

Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Fibrodysplasia Ossificans Progressiva (FOP) Treatment: Introduction

  • Fibrodysplasia ossificans progressiva (FOP) is a very rare inherited connective tissue disorder characterized by the abnormal development of bone in areas of the body where bone is not normally present (heterotopic ossification), such as the ligaments, tendons, and skeletal muscles.
  • This disorder specifically causes the body's skeletal muscles and soft connective tissues to undergo a metamorphosis, essentially a transformation into bone, progressively locking joints in place and making movement difficult or impossible

Key Drivers of Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

  • The global fibrodysplasia ossificans progressiva FOP treatment market is anticipated to expand rapidly in the near few years. Introduction of novel therapies and increase in cases of FOP are likely to be major drivers of the FOP treatment market.
  • Rise in demand for FOP treatment and increase in awareness regarding FOP are also expected to drive the market during the forecast period
  • According to the Journal of Rare Disease Research and Treatment, in 2016, the prevalence of FOP varied substantially from approximately 0.65 per million in North America, 0.47 per million in Western Europe, and 0.27 per million in Latin America to 0.05 per million in Africa and nearly 0.04 per million in the Asia Pacific

Corticosteroids to be Highly Attractive Segment

  • In terms of drug class, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into corticosteroids, NSAIDs, bisphosphonates, and others
  • The corticosteroids segment is expected to account for a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031, owing to a high usage of corticosteroids for the treatment of FOP that may help reduce the intense inflammation and tissue edema seen in the early stages of the disease.

Medication to be Highly Attractive Segment

  • In terms of treatment, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into medication, occupational therapy, and others
  • The medication segment is projected to account for a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031, as medications help in the treatment of disease in the early stages and hence, are prescribed mostly by physicians.

Oral to be Highly Attractive Segment

  • In terms of route of administration, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into oral, topical, and parenteral
  • Oral medications are mostly preferred for the treatment of FOP and hence, the segment is anticipated to hold a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031

Hospital Pharmacies to be Highly Lucrative Segment

  • Based on distribution channel, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be categorized into retail pharmacies, hospital pharmacies, online pharmacies, and others
  • The hospitals segment is anticipated to account for a major share of the market in the next few years due to a rise in the number of FOP treatment in hospitals

North America to Offer Significant Opportunities in Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

  • In terms of region, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America accounted for a significant share of the global market in 2020 owing to favorable healthcare infrastructure, high per capita income, and high rate of adoption of advanced surgeries in the region

Key Players Operating in Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

The global fibrodysplasia ossificans progressiva (FOP) treatment market is semi-consolidated, with the presence of international and local players. Key players operating in the global fibrodysplasia ossificans progressiva (FOP) treatment market are:

  • Pfizer Inc.
  • AstraZeneca
  • DAIICHI SANKYO COMPANY, LIMITED
  • Regeneron Pharmaceuticals, Inc
  • Blueprint Medicines Corporation
  • Clementia
  • Oncodesign
  • La Jolla Pharmaceutical Company
  • Novartis AG
  • Ipsen Pharma
  • BIOCRYST PHARMACEUTICALS, INC.
  • Nobelpharma Co., Ltd

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market: Research Scope

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Drug Class

  • Corticosteroids
  • NSAIDs
  • Bisphosphonates
  • Others

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Treatment

  • Medication
  • Occupational Therapy
  • Surgery

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Route of Administration

  • Oral
  • Topical
  • Parenteral

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  •  Others

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

654

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved